Chronic carvedilol reduces mortality and renal damage in hypertensive stroke-prone rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 2, 1996, Pages 948-955

  Barone, Frank C ^a   Nelson, Allen H ^a   Ohlstein, Eliot H ^a   Willette, Robert N ^a   Sealey, Jean E ^b   Laragh, John H ^b   Campbell Jr , Wallace G ^b   Feuerstein, Giora Z ^a  

^a SmithKline Beecham Pharmaceutical ^*  (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CARVEDILOL; PROPRANOLOL;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CONTROLLED STUDY; HEART HYPERTROPHY; HISTOPATHOLOGY; HYPERTENSION; KIDNEY INJURY; MALE; MORTALITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; STROKE; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ALDOSTERONE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY WEIGHT; CARBAZOLES; HEART RATE; HYPERTENSION; KIDNEY; MALE; PROPANOLAMINES; PROPRANOLOL; RABBITS; RATS; RATS, INBRED SHR; RENIN;

EID: 0030426904     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. AKIGUCHI, I., HOUR, R., OHTAKA, M., YAMORI, Y. AND KAWAI, C.: Symptomatological analysis of stroke in stroke-prone SHR. Jpn. Heart J. 18:547-548, 1977.
2. BLAES, N. AND BOISSEL, J.-P.: Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J. Cell. Physiol. 116: 167-172, 1983.
3. BRIL, A., SLIVJAK, M., DIMARTINO, M. J., FEUERSTEIN, G. Z., LINEE, P., POYSER, R. H., RUFFOLO, R. R., JR. AND SMITH, E. F. III.: Cardioprotective effects of carvedilol, a novel β-adrenoceptor antagonist with vasodilating properties, in anesthetized minipigs; comparison with propranolol. Cardiovasc. Res. 26: 518-525, 1992.
4. BROOKS, D. P., SHORT, B. G., CYRONAK, M. J., CONTINO, L. C., DICRISTO, M., WANG, Y.-X. AND RUFFOLO, R. R., JR.: Comparison between carvedilol and captopril in rats with partial ablation-induced chronic renal failure. Br. J. Pharmacol. 109: 581-586, 1993.
5. BRUNNER, H. R., LARAGH, J. H., BAER, L., NEWTON, M. A., GOODWIN, F. T. AND KRAKOFF, L. R.: Essential hypertension: Renin, aldosterone, heart attack and stroke. N. Engl. J. Med. 286: 441-449, 1972.
6. BÜHLER, F. R., LARAGH, J. H., SEALEY, J. E. AND BRUNNER, H. R.: Plasma aldosterone-renin interrelationships in various forms of essential hypertension. Studies using a rapid assay of plasma aldosterone. Am. J. Cardiol. 32: 554-561, 1973.
7. CAMARGO, M. J. F., VON LUTTEROTTI, N., CAMPBELL, W. G., JR., PECKER, M. S., JAMES, G. D., TIMMERMAN, P. B. AND LARAGH, J. H.: Control of blood pressure and end organ damage in maturing salt-loaded stroke-prone spontaneously hypertensive rats by oral angiotensin II receptor blockade. J. Hypertens. 11: 31-40, 1993.
8. CAMARGO, M. J. F., VON LUTTEROTTI, N., PECKER, M. S., JAMES, G. D., TIMMERMAN, P. B. M. W. M. AND LARAGH, J. H.: DUP 753 increases survival in spontaneoulsy hypertensive stroke-prone rats fed high sodium diet. Am. J. Hypertens. 4: 3415-3455, 1991.
9. DOUGLAS, S. A., GELLAI, M., EZEKIEL, M. AND OHLSTEIN, E. H.: BQ-123, a selective endothelin subtype A-receptor antagonist, lowers blood pressure in different rat models of hypertension. J. Hypertens. 12: 561-567, 1994.
10. EGGERTSEN, R., SIVERTSSON, R., ANDREN, L. AND HANSSON, L.: Acute and long-term hemodynamic effects of carvedilol, a combined beta-adrenoceptor blocking and precapillary vasodilating agent in hypertensive patients. J. Cardiovasc. Pharmacol. 10: (Suppl.) 97-100, 1987.
11. EGGERTSEN, R., SIVERTSSON, R., ANDREN, L. AND HANSSON, L.: Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension. J. Hypertens. 2: 529-534, 1984.
12. FEUERSTEIN, G. Z., HAMBURGER, S. A., SMITH, E. F. III, BRIL, A. AND RUFFOLO, R. R., JR.: Myocardial protection with carvedilol. J. Cardiovasc. Pharmacol. 19: Suppl. 1, S138-S141, 1992.
13. FISHER, M., JONES, S. AND SACCO, R. L.: Prophylactic neuroprotection for cerebral ischemia. Stroke 25: 1075-1080, 1994.
14. GAHNEM, F., VON LUTTEROTTI, N., CAMARGO, M. J. F., LARAGH, J. H. AND SEALEY, J. E.: Angiotensinogen dependency of blood pressure in two high-renin hypertensive rat models. Am. J. Hypertens. 7: 899-904, 1994.
15. GREIS, J., KRETZSCHMAR, R. AND NEUMAN, B. W.: Development of hypertension and life span in stroke prone spontaneously hypertensive rats during oral long-term treatment with various antihypertensive drugs. J. Cardiovasc. Pharmacol. 13: Suppl. 4, S79-S82, 1989.
16. GREIS, J., UNDER, L., EINING, H., FRIEDRICH, L., HOFFMAN, H. P., KREISKOTT, H., LEHMANN, H. D., VON PHILIPSBORN, G., WUPPERMAN, D. AND ZIMMERMAN, F.: Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol. Arznein-Forsch/Drug Res. 38: 1271-1279, 1988.
17. HAMBURGER, S. A., BARONE, F. C., FEUERSTEIN, G. Z. AND RUFFOLO, R. R., JR.: Carvedilol (Kredex®) reduces infarct size in a canine model of acute myocardial infarction. Pharmacology (Basel) 43: 113-120, 1991.
18. KAZDA, S., GARTHOFF, B., AND LUCKHAUS, G.: Calcium-antagonists prevent brain-damage in stroke-prone spontaneously hypertensive rats (SHR-SP) independent of their effect on blood pressure: Nimodipone versus nitrendipine. J. Cerebr. Blood Flow Metab. 3: 526-527, 1983.
19. KRUM, H., SACKNER-BERNSTEIN, J. D., GOLDSMITH, R. L., KUKIN, M. L., SCHWARTZ, B., PENN, J., MEDINA, N., YUSHAK, M., HORN, E., KATZ, S. D., LEVIN, H. R., NEUBERG, G. W., DELONG, G. AND PACKER, M.: Double blind, placebo controlled study of the long-term efficacy of carvedilol in patients with severe heart failure. Circulation 92: 1499-1506, 1995.
20. LARAGH, J. H., BAER, L., BRUNNER, H. G., BÜHLER, F. R., SEALEY, J. E. AND VAUGHAN, E. D., JR.: Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am. J. Med. 52: 633-652, 1972.
21. LYSKO P. G., LYSKO, K. A., WEBB, C. L. AND FEUERSTEIN, G.: Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-D-aspartate receptor. Neurosci. Lett. 148: 34-38, 1992a.
22. LYSKO, P. G., LYSKO, K. A., YUE, T. L., WEBB, C. L., GU, J. L. AND FEUERSTEIN, G.: Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke 23: 1630-1636, 1992b.
23. + channel modulator and glutamate transport inhibitor. Neurosci. Lett. 171: 77-80, 1994.
24. MCPHILLIPS, J. J., SCHWEMER, G. T., SCOTT, D. I., ZINNY, M. AND PATTERSON D.: Effects of carvedilol on blood pressure in patients with mild to moderate hypertension: A dose response study. Drugs 36: Suppl. 6, 82-91, 1988.
25. MIYAGISHI, A., MANIWA, T., NOGUCHI, T. AND HARA, Y.: Prevention of cerebral stroke by arotinol in salt-loaded SHR-SP. Clin. Exp. Hypertens. Theory Prac. A 13: 1077-1089, 1991.
26. NACE, G. S. AND WOOD, A. J. J.: Pharmacokinetics of long acting propranolol: Implications for therapeutic use. Clin. Pharmacokinet. 13: 51-64, 1987.
27. NAGAOKA, A.: Pharmacological prevention of cerebral stroke in stroke-prone spontaneously hypertensive rats. J. Hypertens. 4: Suppl. 3, S523-S525, 1986.
28. NAGAOKA, A., IWATSUKA, H., SOZUSKI, Z. AND OKAMOTO, K.: Genetic predisposition to stroke in spontaneously hypertensive rats. Am. J. Physiol. 230: 1354-1359, 1976.
29. NICHOLS, A. J., GELLAI, M. AND RUFFOLO, R. R., JR.: Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fund. Clin. Pharmacol. 5: 25-38, 1991.
30. NICHOLS, A. J., SULPIZIO, A. C., ASHTON, D. J., HIEBLE, J. P. AND RUFFOLO, R. R., JR.: In vitro pharmacological profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol. Pharmacology (Basel) 327-336, 1989a.
31. 1- and β-adrenoceptors. Chirality 1: 265-270, 1989b.
32. OGIKU, N., SUMIKAWA, H., HASHIMOTO Y. AND ISHIDA R.: Prophylactic effect of imidapril on stroke in stroke-prone spontaneously hypertensive rats. Stroke 24: 245-252, 1993.
33. OHLSTEIN, E. H., DOUGLAS, S. A., SUNG C. P., YUE, T.-L., LOUDEN, C., ARLETH, A., POSTE, G., RUFFOLO, R. R., JR. AND FEUERSTEIN, G. Z.: Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc. Natl. Acad. SCi. U.S.A. 90: 6189-6193, 1993.
34. OHLSTEIN, E. H., VICKERY, L., ARLETH, A., CYRONAK, M., BARONE, F. C., SUNG, C. P., CADOGEN, A. AND MCCARTNEY, L.: Carvedilol, a novel cardiovascular agent, inhibits development of vascular and ventricular hypertrophy in spontaneously hypertensive rats. Clin. Exp. Hypertens. 16: 163-177, 1994.
35. OKAMOTO, K., YAMORI, Y. AND NAGAOKA, A: Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ. Res. 34 and 35: Suppl. 1, 143-153, 1974.
36. RUFFOLO, R. R., JR., BOYLE D. A., VENUTI, R. P. AND LUCAS, M. A.: Carvedilol (Kredex): A novel, multiple action cardiovascular agent. Drugs Today 27: 465-492, 1991.
37. RUFFOLO, R. R., JR., GELLAI, M., HIEBLE, J. P., WILLETTE, R. N. AND NICHOLS, A. J.; THE PHARMACOLOGY OF CARVEDILOL. EUR. J. CLIN. PHARMACOL. 38: (SUPPL.) 82-88, 1990.
38. SEALEY, J. E.: Plasma renin activity and plasma prorenin assays. Clin. Chem. 37: 1811-1819, 1991.
39. 2+ transport in sarcoplasmic reticulum. Cardiovasc. Res. 18: 371-376, 1984.
40. STIER, C. T., BENTER, I. F., AHMAD, S., SUO, H., SELIG, N., ROETHEL, S., LEVINE, S. AND ITSKOVITZ, H. D.: Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 13: 115-121, 1989.
41. SUNDBERG, S., TUHONEN, K. AND GORDIN, A.: Vasodilating effects of carvedilol and pindolol. J. Cardiovasc. Pharmacol. 10: (Suppl) 76-80, 1987.
42. TAKAKURA, S., FURUICHI, Y., YAMAMOTO, T., OGAWA, T. AND SATOH, H.: Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats. Stroke 25: 677-683, 1994.
43. UCHIDA, S., ITOH, M., FUJIMOTO, M., YAMASHITA, K., NIWA, M., SEKINE, I. AND OZAKI, M.: Antihypertensive effects of betaxolol, a cardioselective beta-adrenoceptor antagonist, in stroke prone spontaneously hypertensive rats. Nippon Yakurigaku Zasshi 96: 49-63, 1990.
44. VACHER, E., FORNES, P., DOMERQUE, V., RICHER, C., BRUNEVAL, P. AND GUIDICELLI, J.-F.: Quinapril prevents stroke both during and after the treatment period in stroke-prone spontaneously hypertensive rats. Am. J. Hypertens. 6: 951-959, 1993.
45. + feeding in stroke-prone hypertensive rats. Hypertension 15: 318-326, 1990.
46. VON LUTTEROTTI, N., CARMARGO, M. J. F., CAMPBELL, W. G., JR., MUELLER, F. B., TIMMERMANS, P. B., SEALEY, J. E. AND LARAGH, J. H.: Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats. J. Hypertens. 10: 949-957, 1992.
47. YAMASHITA, K., OHTA, H., UCHIDA, S., SHIGEMATSU, K., OHKUBO, T., NIWA, M. AND OZAKI, M.: Systemic effects of carteolol, a beta-adrenoceptor antagonist in stroke prone spontaneously hypertensive rats. J. Pharmacogiodyn 13: 64-69, 1990.
48. YAMORI, Y., HORIE, R., HANDA, H., SATO, M. AND FUKASE, M.; Pathogenic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7: 46-53, 1976.
49. YAMORI, Y., HORIE, R., AKIGUCHI, I., KIHARA, M., NARA, Y. AND LEVENBERG, W.: Symptomatological classification in the development of stroke in stroke-prone spontaneously hypertensive rats. Jpn. Circ. J. 46: 274-283, 1982.
50. YAMORI, Y., NAGAOKA, A. AND OKAMOTO, K.: Importance of genetic factors in stroke: An evidence obtained by selective breeding of stroke-prone and resistant SHR. Jpn. Circ. J. 38: 1095-1100, 1974.
51. YUE, T. L., CHENG, H. Y., LYSKO, P. G., MCKENNA, P. J., FEUERSTEIN, R., GU, J. L., LYSKO, K. A., DAVIS, L. L. AND FEUERSTEIN, G.: Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J. Pharmacol. Exp. Ther. 263: 92-98, 1992.
52. YUE, T. L., LYSKO, P. G., BARONE, F. C., RUFFOLO, R. R. AND FEUERSTEIN, G. Z.: Carvedilol, a new antihypertensive drug with unique antioxidant activity; potential role in cerebroprotection. N.Y. Acad. SCi. 738: 230-242, 1995.